Prescribe via the SAS-B Pathway for Nurses
While medical cannabis is an effective treatment option for many patients, it’s considered an unapproved good on the TGA’s schedule of drugs. This course is designed to equip healthcare professionals with the skills, knowledge and confidence to navigate the TGA’s Special Access Scheme (SAS) and apply to prescribe medical cannabis to suitable individual patients on a case by case basis using the SAS-B pathway.
We’ll also delve into the broader legal and ethical considerations of prescribing medical cannabis as a treatment option, including risk-mitigation strategies so you can start prescribing medical cannabis to your eligible patients as soon as possible.
On completion of this course, you’ll be able to:
- Define unapproved good
- Describe different pathways for accessing and prescribing unapproved goods
- Explain the differences and correct use of the SAS and Authorised prescriber pathways
- Apply to prescribe medical cannabis for individual patients using the SAS-B pathway
- Explain the legal and ethical considerations, and risk-mitigation strategies when prescribing medical cannabis via the SAS-B pathway
In this program, you will master the SAS-B pathway for prescribing medical cannabis. You will develop an understanding of the variations between the SAS-B pathway and the Authorised Prescriber pathway. Additionally, you will grasp the risks and mitigations within the regulatory framework in Australia.
- Developed by Health Practitioners for Doctors
- Online course, self-paced | Eligible participants can claim CPD hours
- 12 months access
Module 1: Introduction
In this module, you’ll learn about:
- Navigate and complete the course successfully
- Introduce Kai and Zahir
Module 2: Access unapproved goods
In this module, you’ll learn about:
- What is the Australian Register of Therapeutic Goods (ARTG)
- Classification of approved, exempt and unapproved goods as per the ARTG system
- How to identify and access approved and unapproved goods
- The different pathways to access unapproved goods – their purpose, similarities and differences
- When to use the Special Access Scheme (SAS)-B pathway instead of SAS-A or SAS-C
Module 3: Risks, Legalities and Appropriate use
In this module, you'll learn about:
- Appropriate use of the SAS-B pathway
- Identification of necessary information to assess patient suitability for medical cannabis treatment in terms of safety and effectiveness
- Risks associated with prescribing unapproved medications
- Informed consent in the context of medical cannabis treatment
- Scheduling of Medical Cannabis in Australia
- Legislative requirements (including state/territory based requirements)
- Medico-legal and indemnity risks of prescribing medical cannabis
- Reporting requirements for medical cannabis prescribers
- Prescribers’ obligations to provide access to medical cannabis
- Intermediate Principles of Medical Cannabis: Clini...
- Posted By SAGED
- Posted Date: 2024-03-13
- Location:East Melbourne VIC 3002
- Complete this case study treating a patient in palliative care with medical cannabis.
- Intermediate Principles of Medical Cannabis: Clini...
- Posted By SAGED
- Posted Date: 2024-02-13
- Location:East Melbourne VIC 3002
- Complete this case study treating breast cancer and chemotherapy symptoms using medical cannabis.
